Leonteq Securities’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Other funds holding UTHR
Leonteq Securities's UTHR Position: Q3 2026 in Review
Leonteq Securities increased its United Therapeutics (UTHR) stake by 34% in Q3 2026, buying an estimated $11.9K and bringing the position to 91 shares worth $49.3K. The position accounts for ﹤0.01% of the portfolio, ranked #778.
Leonteq Securities first reported a position in UTHR in Q3 2021 and has held it in 20 quarters since. The position peaked at $164K in Q3 2024. 690 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.
- Leonteq Securities held 91 shares of United Therapeutics worth $49.3K as of Q3 2026.
- Leonteq Securities bought 23 United Therapeutics shares in Q3 2026, an estimated $11.9K.
- United Therapeutics made up ﹤0.01% of Leonteq Securities's portfolio in Q3 2026, its #778 holding.
- Leonteq Securities first reported a position in United Therapeutics in Q3 2021 and has held it in 20 quarters since.
- Leonteq Securities's United Therapeutics position peaked at $164K in Q3 2024.
- 690 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.
Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.